Back
Vertex Pharmaceuticals Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
VRTX
Vertex Pharmaceuticals
Last Price:
473.79
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 477.41 | Buy |
| 20-day SMA: | 480.92 | Buy |
| 50-day SMA: | 483.56 | Sell |
| 200-day SMA: | 438.67 | Buy |
| 8-day EMA: | 480.6 | Buy |
| 20-day EMA: | 479.97 | Buy |
| 50-day EMA: | 477.82 | Buy |
| 200-day EMA: | 440.08 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.95 | Buy |
| Chaikin Money Flow: | -230402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (471.81 - 487.79) | Buy |
| Bollinger Bands (100): | (438.87 - 494.43) | Buy |
Vertex Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 481.26 while VRTX 8-day simple moving average is 477.41, which is a Buy signal.
- The stock price of VRTX is 481.26 while Vertex Pharmaceuticals 20-day SMA is 480.92, which makes it a Buy.
- Vertex Pharmaceuticals 50-day simple moving average is 483.56 while VRTX share price is 481.26, making it a Sell technically.
- VRTX stock price is 481.26 and Vertex Pharmaceuticals 200-day simple moving average is 438.67, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
60
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $481.26. The Score for VRTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
124.21B
Price in USD:
481.26
Share Volume:
1.23M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
510.64
52-Week Low:
341.85
Buy
60
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 481.26 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 481.26 while VRTX 8-day exponential moving average is 480.60, which is a Buy signal.
- The stock price of VRTX is 481.26 while Vertex Pharmaceuticals 20-day EMA is 479.97, which makes it a Buy.
- Vertex Pharmaceuticals 50-day exponential moving average is 477.82 while VRTX share price is 481.26, making it a Buy technically.
- VRTX stock price is 481.26 and Vertex Pharmaceuticals 200-day simple moving average is 440.08, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 50.95, which suggest Vertex Pharmaceuticals is overbought
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (471.81 - 487.79), which suggest Vertex Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (438.87 - 494.43), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.